Fate Therapeutics, Inc. (FATE)
NASDAQ
$2.80+0.54%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 1,452,800
- 52-week high
- —
- 52-week low
- —
- Open
- $2.76
- Day high
- $2.89
- Day low
- $2.74
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $6.65M | -$136.32M | -$1.15 |
| 2024 | $13.63M | -$186.26M | -$1.64 |
| 2023 | $63.53M | -$160.93M | -$1.64 |
| 2022 | $96.3M | -$281.72M | -$2.91 |
| 2021 | $55.85M | -$212.15M | -$2.24 |
About Fate Therapeutics, Inc.
A company overview for Fate Therapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Fate Therapeutics, Inc.'s stock price today?
- FATE is trading at $2.80 as of Jul 20, 2026.
- Does Fate Therapeutics, Inc. pay a dividend?
- Fate Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.